These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29914848)

  • 21. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
    Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD
    Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.
    Shah MP; Tate JE; Mwenda JM; Steele AD; Parashar UD
    Expert Rev Vaccines; 2017 Oct; 16(10):987-995. PubMed ID: 28832219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.
    Mwenda JM; Burke RM; Shaba K; Mihigo R; Tevi-Benissan MC; Mumba M; Biey JN; Cheikh D; Poy MSc A; Zawaira FR; Aliabadi N; Tate JE; Hyde T; Cohen AL; Parashar UD
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1192-1196. PubMed ID: 29095805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Lusvan ME; Debellut F; Clark A; Demberelsuren S; Otgonbayar D; Batjargal T; Purevsuren S; Groman D; Tate J; Pecenka C
    Vaccine; 2019 Feb; 37(6):798-807. PubMed ID: 30639458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
    Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global rotavirus vaccine introductions and coverage: 2006 - 2016.
    Abou-Nader AJ; Sauer MA; Steele AD; Tate JE; Atherly D; Parashar UD; Santosham M; Nelson EAS
    Hum Vaccin Immunother; 2018; 14(9):2281-2296. PubMed ID: 29787334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
    PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Rahajamanana VL; Raboba JL; Rakotozanany A; Razafindraibe NJ; Andriatahirintsoa EJPR; Razafindrakoto AC; Mioramalala SA; Razaiarimanga C; Weldegebriel GG; Burnett E; Mwenda JM; Seheri M; Mphahlele MJ; Robinson AL
    Vaccine; 2018 Nov; 36(47):7198-7204. PubMed ID: 28958809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.
    Sanneh B; Papa Sey A; Shah M; Tate J; Sonko M; Jagne S; Jarju M; Sowe D; Taal M; Cohen A; Parashar U; Mwenda JM
    Vaccine; 2018 Nov; 36(47):7179-7184. PubMed ID: 29544688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.
    Page NA; Seheri LM; Groome MJ; Moyes J; Walaza S; Mphahlele J; Kahn K; Kapongo CN; Zar HJ; Tempia S; Cohen C; Madhi SA
    Vaccine; 2018 Nov; 36(47):7231-7237. PubMed ID: 29110933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.